Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease
暂无分享,去创建一个
Y. Asano | Takehiro Takahashi | H. Sumida | A. Yoshizaki | S. Miura | T. Fukasawa | S. Ebata | S. Sato